Treating atopic dermatitis: Safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam

Omar Pacha, Adelaide A. Hebert

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations

Abstract

Advances in current understanding of the pathophysiology of atopic dermatitis have led to improved targeting of the structural deficiencies in atopic skin. Ceramide deficiency appears to be one of the major alterations in atopic dermatitis and the replenishment of this epidermal component through topically applied ceramide based emollients appears to be safe, well tolerated, and effective. Recently a ceramide hyaluronic acid foam has become commercially available and increasing evidence supports its safety and efficacy in patients who suffer from atopic dermatitis.

Original languageEnglish (US)
Pages (from-to)39-42
Number of pages4
JournalClinical, Cosmetic and Investigational Dermatology
Volume5
DOIs
StatePublished - May 5 2012

Keywords

  • Atopic dermatitis
  • Ceramide
  • Dermatology
  • Eczema
  • Hylatopic
  • Non-steroidal

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Treating atopic dermatitis: Safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam'. Together they form a unique fingerprint.

Cite this